Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
41.16
-0.55 (-1.32%)
May 7, 2026, 11:13 AM EDT - Market open
Crinetics Pharmaceuticals Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$76.75
Upside
+86.47%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Maintains $96 → $97 | Buy | Maintains | $96 → $97 | +135.67% | Apr 28, 2026 |
| Citizens | Citizens | Buy Maintains $105 → $96 | Buy | Maintains | $105 → $96 | +133.24% | Mar 2, 2026 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $67 | Hold → Strong Buy | Upgrades | $67 | +62.78% | Jan 12, 2026 |
| Citizens | Citizens | Buy Maintains $108 → $105 | Buy | Maintains | $108 → $105 | +155.10% | Jan 8, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $77 → $80 | Buy | Maintains | $77 → $80 | +94.36% | Jan 6, 2026 |
| Citizens | Citizens | Buy Maintains $143 → $108 | Buy | Maintains | $143 → $108 | +162.39% | Nov 7, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $73 → $87 | Buy | Maintains | $73 → $87 | +111.37% | Sep 30, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $65 → $77 | Buy | Maintains | $65 → $77 | +87.07% | Sep 29, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $80 → $88 | Buy | Maintains | $80 → $88 | +113.80% | Sep 29, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $35 → $40 | Hold | Maintains | $35 → $40 | -2.82% | Sep 26, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $86 → $143 | Buy | Maintains | $86 → $143 | +247.42% | Sep 26, 2025 |
| Baird | Baird | Buy Maintains $58 → $62 | Buy | Maintains | $58 → $62 | +50.63% | Sep 26, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $53 → $52 | Buy | Maintains | $53 → $52 | +26.34% | Sep 24, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $90 → $86 | Buy | Maintains | $90 → $86 | +108.94% | Aug 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $81 | Strong Buy | Reiterates | $81 | +96.79% | Jun 27, 2025 |
| Stifel | Stifel | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +45.77% | Mar 25, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.